The Figure 9A illustrated that FA administration largely corrected glucose tolerance impairment and dramatically reduced fasting glucose, serum insulin, and HOMA-IR levels in PCOS mice (Figure 9B–D). This evidence concerns the gene INS and polycystic ovary syndrome.